MRKR logo

Marker Therapeutics (MRKR) Net Income

Annual Net Income

-$8.24 M
+$21.69 M+72.48%

December 31, 2023

Summary

Performance

1-Year Change

+72.48%

3-Year Change

+71.31%

5-Year Change

+94.43%

15-Year Change

+25%

MRKR Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.31%
MRKR annual net profit is higher than 72.31% of companies in Healthcare sector

High & Low

All-time High

-$384.50 K

3-Year Low

-$41.88 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MRKR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 25, 2025
MRKR next annual earnings announcement is scheduled for Mar 25, 2025

OtherMRKRprofitabilitymetrics:

Annual Net Margin

-
MRKR annual net profit margin value is unknown

Annual Revenue

-
MRKR annual revenue value is unknown

Annual Gross Profit

-
MRKR annual gross profit value is unknown

Annual EPS

-$0.94
MRKR annual earnings per share is -$0.94

Quarterly Net Income

-$2.31 M
-$115.50 K-5.27%

September 30, 2024

Summary

Performance

3-Month Change

-5.27%

1-Year Change

-5.27%

3-Year Change

-5.27%

5-Year Change

+63.6%

MRKR Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.8%
MRKR quarterly net profit is higher than 65.8% of companies in Healthcare sector

High & Low

All-time High

$28.50 M
MRKR quarterly net profit is currently -108.10% below its historical high of $28.50 million

3-Year Low

-$9.91 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MRKR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
MRKR next earnings announcement is scheduled for Mar 25, 2025

OtherMRKRprofitabilitymetrics:

Quarterly Net Margin

-
MRKR quarterly net profit margin value is unknown

Quarterly Revenue

-
MRKR quarterly revenue value is unknown

Quarterly Gross Profit

-
MRKR quarterly gross profit value is unknown

Quarterly EPS

-$0.26
MRKR quarterly earnings per share is -$0.26

TTM Net Income

-$9.70 M
+$673.80 K+6.50%

September 30, 2024

Summary

Performance

3-Month Change

+6.5%

1-Year Change

+6.5%

3-Year Change

+6.5%

5-Year Change

+58.5%

MRKR TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.74%
MRKR TTM net profit is higher than 68.74% of companies in Healthcare sector

High & Low

All-time High

$28.07 M
MRKR TTM net profit is currently -134.54% below its historical high of $28.07 million

3-Year Low

-$43.01 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MRKR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
MRKR next earnings announcement is scheduled for Mar 25, 2025

OtherMRKRprofitabilitymetrics:

Annual Net Margin

-
MRKR annual net profit margin value is unknown

TTM Revenue

-
MRKR TTM revenue value is unknown

TTM Gross Profit

-
MRKR TTM gross profit value is unknown

TTM EPS

-$1.10
MRKR TTM earnings per share is -$1.10

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$8.24 M
MRKR annual net profit is -$8.24 million

Annual Revenue

-
MRKR annual revenue value is unknown

Annual Cost Of Goods Sold

-
MRKR annual cost of goods sold value is unknown

Annual Operating Expenses

$14.58 M
MRKR annual total operating expenses is $14.58 million

Annual Interest Expense

-
MRKR annual interest expense value is unknown

Annual Income Tax

$3700.00
MRKR annual income tax is $3700.00

MRKR Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+72.5%-5.3%+6.5%
3 y3 years+71.3%-5.3%+6.5%
5 y5 years+94.4%+63.6%+58.5%

MRKR Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+80.3%-191.8%+76.7%-71.3%+77.5%
5 y5-yearat high+80.3%-191.8%+81.4%-71.3%+77.5%
alltimeall time-2042.2%+94.4%-108.1%+98.3%-134.5%+93.6%

Marker Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.31 M(+5.3%)
-$9.70 M(-6.5%)
Jun 2024
-
-$2.19 M(-8.4%)
-$10.37 M(+83.2%)
Mar 2024
-
-$2.39 M(-14.6%)
-$5.66 M(-31.3%)
Dec 2023
-$8.24 M(-72.5%)
-$2.80 M(-6.0%)
-$8.24 M(-11.3%)
Sep 2023
-
-$2.98 M(-218.5%)
-$9.29 M(-29.8%)
Jun 2023
-
$2.52 M(-150.6%)
-$13.23 M(-47.1%)
Mar 2023
-
-$4.97 M(+28.8%)
-$24.99 M(-16.5%)
Dec 2022
-$29.93 M(-28.5%)
-$3.86 M(-44.3%)
-$29.93 M(-16.5%)
Sep 2022
-
-$6.92 M(-25.1%)
-$35.84 M(-13.3%)
Jun 2022
-
-$9.24 M(-6.7%)
-$41.35 M(-3.9%)
Mar 2022
-
-$9.91 M(+1.5%)
-$43.01 M(+2.7%)
Dec 2021
-$41.88 M(+45.9%)
-$9.76 M(-21.4%)
-$41.88 M(+3.1%)
Sep 2021
-
-$12.43 M(+14.0%)
-$40.62 M(+14.2%)
Jun 2021
-
-$10.91 M(+24.2%)
-$35.56 M(+14.7%)
Mar 2021
-
-$8.78 M(+3.2%)
-$31.00 M(+8.0%)
Dec 2020
-$28.71 M(+34.0%)
-$8.51 M(+15.4%)
-$28.71 M(+13.6%)
Sep 2020
-
-$7.37 M(+16.2%)
-$25.28 M(+8.2%)
Jun 2020
-
-$6.34 M(-2.2%)
-$23.37 M(+3.4%)
Mar 2020
-
-$6.49 M(+27.7%)
-$22.59 M(+5.4%)
Dec 2019
-$21.43 M(-85.5%)
-$5.08 M(-7.0%)
-$21.43 M(-85.9%)
Sep 2019
-
-$5.46 M(-2.0%)
-$151.91 M(+0.7%)
Jun 2019
-
-$5.57 M(+4.7%)
-$150.84 M(+0.5%)
Mar 2019
-
-$5.32 M(-96.1%)
-$150.08 M(+1.4%)
Dec 2018
-$147.96 M(+1247.3%)
-$135.56 M(+2989.1%)
-$147.96 M(+881.1%)
Sep 2018
-
-$4.39 M(-8.8%)
-$15.08 M(+2.7%)
Jun 2018
-
-$4.81 M(+50.6%)
-$14.68 M(+24.8%)
Mar 2018
-
-$3.20 M(+19.1%)
-$11.76 M(+7.1%)
Dec 2017
-$10.98 M(+347.3%)
-$2.68 M(-32.7%)
-$10.98 M(+11.2%)
Sep 2017
-
-$3.99 M(+110.5%)
-$9.88 M(+23.6%)
Jun 2017
-
-$1.89 M(-21.8%)
-$7.99 M(+6263.9%)
Mar 2017
-
-$2.42 M(+53.5%)
-$125.60 K(-94.9%)
Dec 2016
-$2.46 M(-92.8%)
-$1.58 M(-25.0%)
-$2.46 M(-3.0%)
Sep 2016
-
-$2.10 M(-135.2%)
-$2.53 M(-109.0%)
Jun 2016
-
$5.97 M(-225.8%)
$28.07 M(-173.7%)
Mar 2016
-
-$4.75 M(+187.4%)
-$38.12 M(+11.9%)
Dec 2015
-$34.07 M(+10.3%)
-$1.65 M(-105.8%)
-$34.07 M(+2.8%)
Sep 2015
-
$28.50 M(-147.3%)
-$33.15 M(-47.6%)
Jun 2015
-
-$60.22 M(+8493.7%)
-$63.22 M(+2708.0%)
Mar 2015
-
-$700.70 K(-4.9%)
-$2.25 M(-92.8%)
Dec 2014
-$30.88 M(+458.2%)
-$736.50 K(-53.0%)
-$31.26 M(-8.1%)
Sep 2014
-
-$1.57 M(-308.1%)
-$34.00 M(+1.8%)
Jun 2014
-
$753.50 K(-102.5%)
-$33.40 M(-4.6%)
Mar 2014
-
-$29.71 M(+754.7%)
-$35.02 M(+508.6%)
Dec 2013
-$5.53 M(-10.4%)
-$3.48 M(+259.7%)
-$5.75 M(+32.8%)
Sep 2013
-
-$966.40 K(+11.0%)
-$4.33 M(+4.8%)
Jun 2013
-
-$870.80 K(+97.3%)
-$4.13 M(-31.3%)
Mar 2013
-
-$441.40 K(-78.5%)
-$6.01 M(-2.5%)
Dec 2012
-$6.17 M
-$2.05 M(+167.3%)
-$6.17 M(+63.8%)
Sep 2012
-
-$768.10 K(-72.1%)
-$3.77 M(-2.0%)
Jun 2012
-
-$2.75 M(+359.4%)
-$3.84 M(+156.6%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$598.60 K(-271.5%)
-$1.50 M(-30.9%)
Dec 2011
-$2.03 M(-42.6%)
$349.10 K(-141.3%)
-$2.17 M(+5.1%)
Sep 2011
-
-$844.30 K(+108.8%)
-$2.06 M(-7.6%)
Jun 2011
-
-$404.40 K(-68.1%)
-$2.23 M(-29.5%)
Mar 2011
-
-$1.27 M(-378.6%)
-$3.17 M(-10.4%)
Dec 2010
-$3.53 M(-79.9%)
$455.00 K(-144.9%)
-$3.53 M(-51.7%)
Sep 2010
-
-$1.01 M(-24.3%)
-$7.32 M(+3.1%)
Jun 2010
-
-$1.34 M(-18.0%)
-$7.10 M(-62.2%)
Mar 2010
-
-$1.63 M(-51.0%)
-$18.78 M(+6.7%)
Dec 2009
-$17.60 M(+701.4%)
-$3.33 M(+321.5%)
-$17.60 M(+8.7%)
Sep 2009
-
-$790.90 K(-93.9%)
-$16.19 M(-5.3%)
Jun 2009
-
-$13.02 M(+2778.4%)
-$17.11 M(+209.7%)
Mar 2009
-
-$452.40 K(-76.5%)
-$5.52 M(-3.9%)
Dec 2008
-$2.20 M(-43.6%)
-$1.93 M(+13.2%)
-$5.75 M(+16.6%)
Sep 2008
-
-$1.70 M(+18.6%)
-$4.93 M(+30.6%)
Jun 2008
-
-$1.44 M(+112.4%)
-$3.78 M(+19.9%)
Mar 2008
-
-$676.80 K(-39.1%)
-$3.15 M(-19.0%)
Dec 2007
-$3.89 M(+198.3%)
-$1.11 M(+101.7%)
-$3.89 M(+23.0%)
Sep 2007
-
-$550.70 K(-32.1%)
-$3.16 M(+2.5%)
Jun 2007
-
-$811.60 K(-42.8%)
-$3.08 M(+23.1%)
Mar 2007
-
-$1.42 M(+270.8%)
-$2.51 M(+100.0%)
Dec 2006
-$1.30 M(+31.8%)
-$382.40 K(-19.0%)
-$1.25 M(+17.8%)
Sep 2006
-
-$472.30 K(+102.1%)
-$1.06 M(+17.8%)
Jun 2006
-
-$233.70 K(+41.9%)
-$903.30 K(-20.0%)
Mar 2006
-
-$164.70 K(-14.8%)
-$1.13 M(+14.1%)
Dec 2005
-$989.60 K(-63.1%)
-$193.30 K(-38.0%)
-$989.50 K(-47.6%)
Sep 2005
-
-$311.60 K(-32.2%)
-$1.89 M(-4.4%)
Jun 2005
-
-$459.70 K(+1746.2%)
-$1.98 M(-3.0%)
Mar 2005
-
-$24.90 K(-97.7%)
-$2.04 M(-24.0%)
Dec 2004
-$2.68 M(-53.6%)
-$1.09 M(+173.7%)
-$2.68 M(-36.4%)
Sep 2004
-
-$399.40 K(-23.4%)
-$4.22 M(-12.3%)
Jun 2004
-
-$521.30 K(-22.2%)
-$4.81 M(-13.6%)
Mar 2004
-
-$669.70 K(-74.5%)
-$5.57 M(-3.5%)
Dec 2003
-$5.78 M(+152.9%)
-$2.63 M(+164.9%)
-$5.78 M(+34.7%)
Sep 2003
-
-$993.10 K(-22.4%)
-$4.29 M(+11.6%)
Jun 2003
-
-$1.28 M(+46.4%)
-$3.85 M(+8.1%)
Mar 2003
-
-$874.60 K(-23.5%)
-$3.56 M(+22.0%)
Dec 2002
-$2.28 M(+494.2%)
-$1.14 M(+109.2%)
-$2.92 M(+61.0%)
Sep 2002
-
-$546.50 K(-44.9%)
-$1.81 M(+37.1%)
Jun 2002
-
-$992.30 K(+326.4%)
-$1.32 M(+527.1%)
Mar 2002
-
-$232.70 K(+487.6%)
-$210.70 K(-45.2%)
Dec 2001
-$384.50 K(-70.2%)
-$39.60 K(-30.2%)
-$384.50 K(-42.1%)
Sep 2001
-
-$56.70 K(-147.9%)
-$664.60 K(-27.8%)
Jun 2001
-
$118.30 K(-129.1%)
-$921.10 K(-31.9%)
Mar 2001
-
-$406.50 K(+27.2%)
-$1.35 M(+9.9%)
Dec 2000
-$1.29 M(+14.6%)
-$319.70 K(+2.1%)
-$1.23 M(+35.1%)
Sep 2000
-
-$313.20 K(+0.2%)
-$910.20 K(+52.5%)
Jun 2000
-
-$312.70 K(+10.0%)
-$597.00 K(+110.0%)
Mar 2000
-
-$284.30 K
-$284.30 K
Dec 1999
-$1.13 M
-
-

FAQ

  • What is Marker Therapeutics annual net profit?
  • What is the all time high annual net income for Marker Therapeutics?
  • What is Marker Therapeutics annual net income year-on-year change?
  • What is Marker Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Marker Therapeutics?
  • What is Marker Therapeutics quarterly net income year-on-year change?
  • What is Marker Therapeutics TTM net profit?
  • What is the all time high TTM net income for Marker Therapeutics?
  • What is Marker Therapeutics TTM net income year-on-year change?

What is Marker Therapeutics annual net profit?

The current annual net income of MRKR is -$8.24 M

What is the all time high annual net income for Marker Therapeutics?

Marker Therapeutics all-time high annual net profit is -$384.50 K

What is Marker Therapeutics annual net income year-on-year change?

Over the past year, MRKR annual net profit has changed by +$21.69 M (+72.48%)

What is Marker Therapeutics quarterly net profit?

The current quarterly net income of MRKR is -$2.31 M

What is the all time high quarterly net income for Marker Therapeutics?

Marker Therapeutics all-time high quarterly net profit is $28.50 M

What is Marker Therapeutics quarterly net income year-on-year change?

Over the past year, MRKR quarterly net profit has changed by -$115.50 K (-5.27%)

What is Marker Therapeutics TTM net profit?

The current TTM net income of MRKR is -$9.70 M

What is the all time high TTM net income for Marker Therapeutics?

Marker Therapeutics all-time high TTM net profit is $28.07 M

What is Marker Therapeutics TTM net income year-on-year change?

Over the past year, MRKR TTM net profit has changed by +$673.80 K (+6.50%)